Role of capecitabine in treating metastatic colorectal cancer in Chinese patients

@inproceedings{Wang2014RoleOC,
  title={Role of capecitabine in treating metastatic colorectal cancer in Chinese patients},
  author={Feng Wang and Fenghua Wang and Long Bai and Ruihua Xu},
  booktitle={OncoTargets and therapy},
  year={2014}
}
The China Food and Drug Administration approved the use of capecitabine in patients with metastatic colorectal cancer (mCRC) in 2004. This paper reviews the available information of capecitabine in Chinese patients with mCRC, focusing on its effectiveness and safety against mCRC. Identification of all eligible studies was made by searching the PubMed and… CONTINUE READING